Strive Health, a kidney care decision-making platform, secured a $140 million Series B round of funding led by CapitalG, Alphabet’s independent growth fund.
Redpoint, New Enterprise Associates (NEA), Town Hall Ventures, Ascension Ventures, and Echo Ventures also participated in the funding round.
Including the latest funding round, Strive Health has raised $223.5 million to date. According to the company, the financing will support the growing demand for its whole-patient solution for kidney disease populations.
According to Strive Health, its artificial intelligence (AI)-powered data science models predict disease progression with more than 95% accuracy. The technology helps caregivers personalize care for each patient, identify disease progression and make predictions about a patient’s condition. The technology also enabled caregivers to communicate and share recommendations.
The company plans to use the new funds to accelerate go-to-market efforts. “Our focus is on providing great patient care. Technology is a critical aspect of doing this well, and our unique partnership with CapitalG will help us profoundly elevate our growth and technology vision by leveraging the insights and expertise of the best and brightest minds at Google and Alphabet,” said Chris Riopelle, CEO of Strive Health.
Strive Health clients include healthcare payors and providers, including Humana, Blue Cross and Blue Shield of North Carolina, SSM Health, and Conviva Care Centers.
“Our focus is on providing great patient care. Technology is a critical aspect of doing this well, and our unique partnership with CapitalG will help us profoundly elevate our growth and technology vision by leveraging the insights and expertise of the best and brightest minds at Google and Alphabet,” said Chris Riopelle, CEO of Strive Health. “We are thrilled by how this partnership will take us to the next level and enable compassionate kidney care the way it should be done.”
Clinical decision support software companies have raised $5 billion since 2010, according to Mercom’s digital funding data. Recently, Caption Health, an artificial intelligence (AI)-powered diagnostics and decision-making software, closed its Series B funding of $53 million. Data Collective (DCVC) led the financing round with participation from other investors.
